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Purpose: Current accepted cerebrovascular reactivity indices suffer from the need of high frequency 
data capture and export for post-acquisition processing.  The role for minute-by-minute data in 
cerebrovascular reactivity monitoring remains uncertain. The goal was to explore the statistical time-
series relationships between intra-cranial pressure (ICP), mean arterial pressure (MAP) and pressure 
reactivity index (PRx) using both 10-second and minute data update frequency in TBI.   
Methods: Prospective data from 31 patients from 3 centers with moderate/severe TBI and high-
frequency archived physiology were reviewed. Both 10-second by 10-second and minute-by-minute 
mean values were derived for ICP and MAP for each patient. Similarly, PRx was derived using 30 
consecutive 10-sec data points, updated every minute. While long-PRx (L-PRx) was derived via similar 
methodology using minute-by-minute data, with L-PRx derived using various window lengths (5, 10, 20, 
30, 40, and 60 minutes; denoted L-PRx_5, etc.). Time-series autoregressive integrative moving average 
(ARIMA) and vector autoregressive integrative moving average (VARIMA) models were created to 
analyze the relationship of these parameters over time.  
Results:  ARIMA modelling, Granger causality testing and VARIMA impulse response function (IRF) 
plotting demonstrated that similar information is carried in minute mean ICP and MAP data, compared 
to 10-second mean slow-wave ICP and MAP data. Shorter window L-PRx variants, such as L-PRx_5, 
appear to have a similar ARIMA structure, have a linear association with PRx and display moderate-to-
strong correlations (r~0.700, p<0.0001 for each patient). Thus, these particular L-PRx variants appear 
closest in nature to standard PRx. 
Conclusions:  ICP and MAP derived via 10-sec or minute based averaging display similar statistical time-





similarly over time. These results imply certain L-PRx variants may carry similar information to PRx in 







Cerebrovascular reactivity monitoring in adult traumatic brain injury (TBI) is becoming increasingly 
common in the critical care management of moderate and severe TBI.[1,2] Impaired cerebrovascular 
reactivity has been linked to worse global outcome in adult TBI at 6 months,[3–6] and appears 
independent of current intensive care unit (ICU) therapies for TBI.[7,8]  
Various metrics for continuous monitoring of cerebrovascular reactivity have been described in adult 
TBI, based on the invasive/non-invasive modalities employed for monitoring cranial physiology. The 
intra-cranial pressure (ICP) based measures have received the most attention, with the pressure 
reactivity index (PRx) considered the standard by many.[9] PRx is one of the few indices with some 
experimental literature to support its ability to detect the lower limit of autoregulation during both 
arterial hypotension and intra-cranial hypertension.[10–12] Furthermore, impaired vascular reactivity, 
as measured through PRx, has an extensive body of literature supporting its association with poor global 
outcome,[4,5] cerebral metabolic dysfunction[13,14] and impaired cerebral oxygen delivery.[9,15] 
However, despite the promising nature of PRx, it has limitations.  One important limitation is the data 
required for derivation.  PRx is based on the concept that the correlation between slow-wave vasogenic 
fluctuations in a measure of cerebral blood volume (such as ICP) and a driver of cerebral blood flow 
(such as mean arterial pressure (MAP)), provide a surrogate measure of cerebral autoregulation.[3] As 
such, the calculation of standard PRx requires 10-second by 10-second mean values of ICP and MAP, 
focusing on the slow-wave frequency range of 0.05 to 0.005Hz.[16,17]  Most bedside monitors in the 
ICU employed globally struggle to provide data export at such a frequency, with most providing minute-
by-minute data as their highest export frequency. As such, PRx has classically required third party 





Given this, there has been an attempt to utilize minute-by-minute ICP and MAP data to derive low 
resolution, or low frequency, versions of PRx, termed long-PRx (L-PRx), with the aim to increase 
accessibility to such monitoring.[18–20] Such measures have shown moderate correlation with standard 
PRx, and an association with global outcome in adult TBI, in small populations, and likely capture the 
low-frequency end of the vasogenic frequency range.  
Despite this, there exists uncertainty as to whether minute-by-minute ICP and MAP data behave 
similarly to higher frequency 10-second mean data, and whether L-PRx carries similar information to PRx 
over time.  Previous works focused mainly on the correlation between large averaged time periods of 
data, not focusing on the statistical properties of the parent signals. In the absence of a direct gold 
standard reproducible measure of autoregulation or cerebral blood flow in vivo, we cannot directly 
compare measures such as PRx and L-PRx to flow or vascular regulation.  Thus, we are left with exploring 
the relationships of these derived signals, their structure statistically and behavior over time, in order to 
make more definitive comments as to whether L-PRx metrics provide close surrogate measure of PRx 
and may be employed clinically. As such, the goal of this study was to evaluate the statistical time-series 
relationships between ICP, MAP and PRx/L-PRx using both data derived from 10-second and minute-







Patients:  Patient data was accrued retrospectively from three centers with archived high resolution 
physiologic data, with two from Nordic countries (Helsinki University Hospital,Helsinki, Finland, and the 
Karolinska University Hospital, Stockholm, Sweden), and one from Canada (Winnipeg Health Sciences 
Centre). All patients were studied during January 2015 to February 2019. All patients from Stockholm 
and Helsinki were also part the multi-center Collaborative European Neuro Trauma Effectiveness 
Research in TBI (CENTER-TBI) study high-resolution ICU sub-study cohort.[21]  These patients were 
prospectively recruited during the periods of January 2015 to December 2017. Patients from Winnipeg 
were studied as part of an ongoing prospective high-resolution TBI database, started in early 2018. 
All patients suffered predominantly from moderate to severe TBI (moderate = Glasgow Coma Score 
(GCS) 9 to 12, and severe = GCS of 8 or less).  A minority of patients suffered from mild TBI (GCS13-15), 
with subsequent early deterioration leading to ICU admission for care and monitoring.  All patients in 
this cohort had invasive ICP monitoring conducted in accordance with the BTF guidelines.[22]  
 
Ethics:  Data from Stockholm and Helsinki were collected as part of the CENTER-TBI study which had 
individual national or local regulatory approval ((Stockholm 2014-11473-31/4, Helsinki 21.10.2014, Dnro 
ETMK: 95/1801/2014).  The CENTER-TBI study (EC grant 602150) has been conducted in accordance with 
all relevant laws of the EU if directly applicable or of direct effect and all relevant laws of the country 
where the Recruiting sites were located, including but not limited to, the relevant privacy and data 
protection laws and regulations (the “Privacy Law”), the relevant laws and regulations on the use of 
human materials, and all relevant guidance relating to clinical studies from time to time in force 
including, but not limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice 





“Ethical Principles for Medical Research Involving Human Subjects”. Informed Consent by the patients 
and/or the legal representative/next of kin was obtained, accordingly to the local legislations, for all 
patients recruited in the Core Dataset of CENTER-TBI and documented in the e-CRF. 
Data from the Winnipeg cohort was collected in accordance with full local health research ethics board 
approval from the University of Manitoba (H2017:181, H2017:188, and H2019:157).  
 
Data Collection: All patients had demographics prospectively recorded.  Similarly, all patients had high 
frequency digital signals from ICU monitoring recorded throughout their ICU stay, with the goal of 
initiating recording within 24 hours of ICU admission.  All digital ICU signals were further processed (see 
Signal Acquisition/Signal Processing). For the purpose of this study, the following admission 
demographic variables were retrospectively collected:  age, sex, admission Glasgow Coma Scale (GCS – 
total and motor) and admission pupillary response (bilaterally reactive, unilateral reactive, bilateral 
unreactive). CENTER-TBI data was accessed/extracted using Opal database software[23] for the 
Stockholm and Helsinki data. 
 
Signal Acquisition:  Arterial blood pressure (ABP) was obtained through either radial or femoral arterial 
lines connected to pressure transducers (Baxter Healthcare Corp. CardioVascular Group, Irvine, CA, or 
similar devices).  ICP was acquired via an intra-parenchymal strain gauge probe (Codman ICP 
MicroSensor; Codman & Shurtleff Inc., Raynham, MA), parenchymal fiber optic pressure sensor (Camino 
ICP Monitor, Integra Life Sciences, Plainsboro, NJ, United States; https://www.integralife.com/) or 
external ventricular drain (in 3 patients).  All signals were recorded using digital data transfer or digitized 
via an A/D converter (DT9801; Data Translation, Marlboro, MA), where appropriate, sampled at 





UK, http://icmplus.neurosurg.cam.ac.uk) or Moberg CNS Monitor (Moberg Research Inc, Ambler, PA, 
USA) or a combination of both.  Signal artifacts were removed using both manual and automated 
methods prior to further processing or analysis. 
 
Signal Processing: Post-acquisition processing of the above signals was conducted using ICM+. Only the 
acute ICU physiology was utilized for this study (ie. the first 5 days after injury). For ICP and MAP, two 
sets of data were produced. First, 10-second moving averages (updated every 10 seconds to avoid data 
overlap) were calculated for all recorded signals:  ICP and ABP (which produced MAP).  Second, minute-
by-minute averages were also created for both ICP and MAP. 
Next, we derived PRx and L-PRx variants for each patient. PRx was derived via the moving correlation 
coefficient between 30 consecutive 10 second mean windows of the parent signals (ICP and MAP), 
updated every minute.  This methodology for PRx determination has been employed for over 20 years, 
with this metric having been preliminarily validated as a measure of the lower limit of autoregulation in 
experimental animal models.[3]  Finally, L-PRx was derived using minute-by-minute mean values of ICP 
and MAP, with various window lengths for calculation, updated every minute.  The window lengths used 
for L-PRx were: 5, 10, 20, 30, 40 and 60 minute windows. This created the following respective L-PRx 
variants: L-PRx_5, L-PRx_10, L-PRx_20, L-PRx_30, L-PRx_40, and L-PRx_60; based on previous literature 
on low-frequency PRx variants in TBI.[18–20] 
 
Statistics:  All statistical analysis were conducted using R (R Core Team (2016). R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
https://www.R-project.org/) and XLSTAT (Addinsoft, New York, NY; https://www.xlstat.com/en/) add-on 





For all testing described within, the alpha was set at 0.05 for significance. Given the bounded nature of 
PRx and L-PRx variables, all cerebrovascular reactivity indices were transformed using a Fisher natural 
logarithmic transformation. Thus, for all reference to PRx and L-PRx within the manuscript, we are 
referring to the Fisher transformed indices. Similarly, ICP and MAP were transformed using a logarithmic 
transformation, and for all reference to ICP and MAP within the manuscript we are referring to log10 
transformed values. 
We currently lack a direct, reliable and reproducible continuous measure of cerebral autoregulation and 
cerebral blood flow in vivo in humans. As such, previous studies have tried to validate PRx against the 
Lassen curve,[24] in particular the lower limit of autoregulation, in experimental animal models.[10–12] 
To date, PRx has the largest supporting evidence as a continuous metric of cerebrovascular reactivity in 
adult TBI. To validate L-PRx, in the absence of human or animal studies evaluating it against the 
autoregulatory curve, we must rely on its relationship and behavior with respect to PRx. Doing so 
requires evaluating the derived signal structures of PRx and L-PRx variants over time statistically, using 
various time series methodologies (see sub-sections to follow). In theory, if the structure and behavior 
of L-PRx is similar to PRx, then one could say that L-PRx may provide similar information to PRx. Studies 
like this may provide preliminary support for the use of L-PRx clinically in TBI. 
 ICP and MAP Analysis 
ICP and MAP were analyzed in both 10-second by 10-second and minute-by-minute mean value data 
sheets, per patient. The time series characteristics of ICP and MAP were independently evaluated in 
each patient, using Box-Jenkin’s autoregressive integrative moving average (ARIMA) models.[25–27] 
First, both ICP and MAP were evaluated for time stationarity and trend using: autocorrelation function 
(ACF) plots, partial autocorrelation function (PACF) plots, augmented Dickey-Fuller (ADF) test for root 





stationary ICP and MAP time-series in each patient.  As such, a first order differencing was introduced to 
each, and the above-mentioned tests repeated to demonstrate stationary behavior.  
Next, the optimal ARIMA structure for ICP and MAP were derived in both the 10-second and minute 
mean data sheets, for each patient. The auto.arima function was initially employed to determine the 
upper order limit for tested ARIMA models. Based on this, autoregressive order (p) was varied from 1 to 
4, and the moving average order (q) was varied from 1 to 4, while the integrative order (d) was held at 1.  
All subsequent permutations of the ARIMA orders were assessed, with the model Akaike Information 
Criterion (AIC) and Log-Likelihood (LL) recorded for every model, for both ICP and MAP, in every patient.  
Using the AIC and LL, the optimal ARIMA structures for ICP and MAP variables were compared in the 10-
second and minute mean data sheets, with the lowest AIC and highest LL values indicating superior 
models. As an example, the general Box-Jenkin’s ARMA model for ICP can be expressed as follows: 
 
ICPt = c + εt + ∑ 𝜑
𝑝
𝑖=1 t-i ICPt-i + ∑ 𝜃
𝑞
𝑗=1 t-j εt-j 
 
Where: c= constant, t = time “t”, i = integer, j = integer, p = autoregressive order, ICP = intra-
cranial pressure, q = moving average order, 𝜑 = autoregressive coefficient at time “t-i”, 𝜃 = 
moving average coefficient at time “t-j”, 𝜀 = error term. 
 
Subsequently, the influence of ICP and MAP on one another over time was assessed via Granger 





and the impact of MAP on ICP tested. This was tested in both the 10-sec and minute mean data sheets, 
for every patient. Both F-test statistic value and p-values were recorded. 
Finally, in order to further evaluate if 10-sec or minute based mean data made a difference in the 
behavior of ICP and MAP over time, we derived multi-variate vector ARIMA (VARIMA) models.   Such 
models explore the behavior of two time series recorded simultaneously over time, and are derived via 
extending the standard Box-Jenkin’s models to multi-variate systems.[25,27,28] Further description on 
this technique can be found in the references. The vector autoregressive moving average model 
(VARMA) of first order difference ICP and MAP can be represented by the following formula: 
 
Yt = C + Et   ∑ 𝐴
𝑝
𝑖=1 t-i Yt-i + ∑ 𝐵
𝑞
𝑗=1 t-j Et-j  
 
Where: C= constant vector, t = time “t”, i = integer, j = integer, p = VARMA autoregressive order, 
Y = ICP and MAP vector, q = VARMA moving average order, A = autoregressive coefficient matrix 
at “t-i”, B = moving average coefficient matrix at time “t-j”, E = error term vector. 
We utilized differenced ICP and MAP signals, to eliminate trend and seasonality, and employed basic 
VARMA models with autoregressive order of 4 and moving average order of 4, based on the findings 
from individual patient ARIMA models of ICP and MAP, for both the 10-sec and minute mean based 
data, for each patient. The VARMA model autoregressive order of 4 was chosen given the optimal 
ARIMA models for ICP and MAP in most patients had autoregressive orders of 2, and thus the product of 
these orders is 4.  Taking the product of the ARIMA autoregressive orders for VARMA modelling is one 





Similarly, the moving average order for the VARMA model was based on the sum of the optimal moving 
average orders from the ARIMA modelling[27] of ICP and MAP, with an order of 2 being the most 
commonly displayed optimal order for ICP and MAP.  Given this was a pilot exploratory analysis, this 
general (4,1,4) VARIMA model structure was employed for each patient. The coefficients derived from 
these VARMA models were then employed to derive impulse response function (IRF) plots between ICP 
and MAP.  The IRF plots provide a descriptive graphical representation of the impact of ICP on MAP, and 
MAP on ICP, by using the generated VARIMA model and modelling a one unit orthogonal impulse of one 
variable on the other, and vice versa.[27]  The plots depict how much from baseline one variable 
fluctuates in response to the orthogonal impulse of the other variable, and how many lags in time it 
takes to recover back to baseline. 
 
 PRx and L-PRx Analysis 
Using minute-by-minute updated PRx and L-PRx data, the following analysis was conducted. For each 
patient, locally weighted scatterplot smoothing (LOESS) function plots were created between PRx and 
each L-PRx variant, assessing the degree of linearity between each L-PRx metric and the conventional 
PRx. Next, Pearson correlation coefficients between PRx and L-PRx were determined for each patient, 
for each variant of L-PRx. Of note, the degree of statistical significance of the linear models and Pearson 
correlation coefficients are artificially increased secondary to autocorrelation between minute-by-
minute updated measures, and violation of the pre-conditions of linearity. As such, both the linear 
model plots and correlation coefficients reported are for purely descriptive purposes only, and the size 
of the p-value or nature of the confidence intervals should be interpreted with caution.  
Finally, the optimal ARIMA time-series structure was compared for PRx and all L-PRx variants for each 





ADF and KPSS testing were conducted, for all PRx/L-PRx measures, confirming non-stationarity. First 
order differencing was then undertaken to remove all trend components, confirming stationarity by 
repeating the above-mentioned plots and testing. Next ARIMA models were built for each PRx and L-PRx 
variable, keeping the differencing order of 1 (ie. d = 1), and varying both the autoregressive and moving 
average orders (ie. p and q, respectively) from 0 to 4, through all respective permutations. The AIC and 
LL were then tabulated for each of these models, for every patient.  Using the AIC and LL, the optimal 
ARIMA structures for PRx and L-PRx variables were compared, with the lowest AIC and highest LL values 
indicating superior models. 
Outcome Analysis 
We briefly evaluated the association with outcome for PRx and the derived L-PRx metrics. Employing 
univariate logistic regression, we assessed the association between PRx and L-PRx measures to 
dichotomized Glasgow Outcome Scale Extended (GOSE) at 6 months post-injury. We evaluated both 
mortality and favourable/unfavourable outcome (defined as GOSE 5 or above for favourable outcome). 
Models were assessed by area under the receiver operating curve (AUC), Akaike Information Criterion 
(AIC) and 95% confidence intervals (95% CI), with alpha set at 0.05 for significance. AUC and 95% CI were 
determined through a bootstrap resampling methodology, employing 2000 iterations.  
Results: 
Patient Demographics 
A total of 31 patients from the three centers were included in this study. The mean age was 41.7 +/- 
13.6 years, with 23 (74.2%) male. The median admission total GCS score and motor sub-scores were 6 
(IQR: 3 to 8) and 4 (IQR: 1 to 5), respectively. Three patients (9.7%) suffered pre-hospital hypoxic 
episodes, and three (9.7%) suffered hypotension episodes. Ten patients (32.3%) presented with 





high frequency digital signal recording was 108.3 +/- 50.7 hours. Table 1 displays the patient admission 
demographics and injury information. Figure 1 displays a patient example of PRx and some L-PRx 
variants over time, highlighting the loss of information with larger L-PRx window lengths. 
 
*Table 1 here 
*Figure 1 here 
 
 
ICP and MAP Analysis – ARIMA Structure 
We evaluated the ARIMA time-series structure for both ICP and MAP, in every patient, using log 
transformed and first order differenced data (of note, this transformed and differenced data was 
utilized for all parts of the ICP and MAP analysis). This was conducted in both 10-second and minute 
mean data. Appendix A displays a patient example of the AIC and LL for each ARIMA model tested, in 
both data sheets. In general, the optimal ARIMA structure for ICP and MAP varied between patients, 
given inter-patient heterogeneities.  However, comparing the ARIMA structures of ICP and MAP 
between the 10-second and minute averaged data, there was no substantial difference in the optimal 
ARIMA models.  This suggests that the time-series behavior is similar for 10-second average vasogenic 
slow-wave ICP and MAP data, compared to minute-by-minute ICP and MAP data.  
 





In order to further assess for differences between 10-second and minute mean data for ICP and MAP 
(transformed and differenced), we performed Granger causality testing in both sets of data for all 
individual patients. For most patients, the directional nature of the causal relationship regardless of 
whether 10-second or minute mean data were assessed, favored MAP impacting ICP. A small minority of 
patients displayed the alternative causal relationship.  Table 2 provides the Granger test results, 
including F-test and p values, for every patient. Of note, the causal direction of the ICP and MAP 
relationship was unchanged, regardless of testing on 10-second or minute mean data.  This suggests 
that minute-by-minute mean data does not lose information regarding the ICP and MAP relationship, 
which is seen in 10-second vasogenic slow-wave data.   
 
*Table 2 here 
 
ICP and MAP Analysis – VARMA and Impulse Response 
Finally, to assess the relationship between ICP and MAP further, and whether there was a difference in 
information carried between 10-second and minute mean data, we employed VARIMA modelling. 
VARIMA models of autoregressive order 4, integrative order 1, and moving average order 4 were 
employed for each individual patient, for both the 10-second and minute mean data. IRF plots were 
produced to provide a descriptive visualization of the relationship between ICP and MAP, in both data 
sets.  These IRF plots allowed us to visually determine the relationship between ICP and MAP, assessing 
the impact of one unit impulse in MAP on ICP, using transformed data. 
Overall, using minute mean data led to similar absolute changes in the ICP standard error, with some 





minute mean data.  This was seen in all patients, and confirms that some information regarding the 
slow-wave relationship between ICP and MAP is lost in the minute mean data, however there is 
preservation of the overall general shape of response of ICP to changes in MAP.  This, suggests that the 
minute mean data does indeed contain some information regarding cerebrovascular reactivity. Figure 2 
displays the IRF plots for two patient examples, highlighting the similar ICP response to a MAP impulse.  
*Figure 2 here 
PRx and L-PRx Variants – Linear Relationships 
For each individual patient the linear relationship between PRx and L-PRx variants was assessed using 
LOESS plots, Pearson correlations and Bland-Altman Analysis. Table 3 provides the Pearson correlation 
between PRx and the L-PRx variants for every patient. Overall, PRx was most closely associated with L-
PRx_5, with the highest Pearson correlation values (~0.700, p<0.0001 for all patients) and visually the 
strongest linear relationship on LOESS analysis. Similarly, Bland-Altman analysis confirmed in every 
patient to display a consistent overestimation bias of L-PRx_5.  All other L-PRx variants performed poorly 
in comparison to standard PRx.  Figure 3 displays a patient example of LOESS and Bland-Altman plots for 
PRx vs. L-PRx_5, and PRx vs. L-PRx_30.  
 
PRx and L-PRx Variants – ARIMA Structure 
Finally, the ARIMA time-series structure for PRx and L-PRx variants were assessed in each patient. 
Appendix B provides some patient examples of the ARIMA analysis, documenting the ARIMA model, AIC 
and LL. As with ICP and MAP testing, the optimal ARIMA model for PRx and L-PRx variants, was patient 
dependent.  However, in general, PRx and the small window length versions of L-PRx (ie. L-PRx_5 and L-





lengths for calculation were increasingly dissimilar to standard PRx based on optimal ARIMA structure, 
as seen in every patient.  
*Table 3 here 
 
*Figure 3 here 
Outcome Association 
We performed univariate logistic regression analysis between mean PRx and L-PRx metrics with 
dichotomized GOSE at 6 months. In keeping with other studies, these PRx/L-PRx metrics displayed 
stronger association with mortality than favourable/unfavourable outcome.[18–20] The AUC for all PRx 
and L-PRx measures were not statistically different, with large overlapping 95% CI’s, consistent with such 
a small cohort. However, despite the limited conclusions that can be made, we can say that the L-PRx 
metrics display statistically significant associations with mortality at 6 months, as does PRx. All metrics 
failed to display a significant association with favourble/unfavourable outcome at 6 months. Appendix C 




Given the absence of direct, reliable and reproducible metrics of cerebral autoregulation and cerebral 
blood flow in vivo in adult TBI, to evaluate whether L-PRx is similar to PRx, we must rely on investigating 
the statistical relationships between high-frequency fluctuations in the derived signals.  To do so 
requires evaluating such behavior over time between both the parent signals used to derive PRx and L-





complex time-series analyses via ARIMA, VARMA and Granger causality testing. Through in-depth 
evaluation of the relationship between ICP and MAP, using 10-second and minute based mean data, and 
comparing standard PRx to L-PRx variants, some important insights into lower resolution 
cerebrovascular reactivity metrics have been made. This provides some preliminary evidence to support 
that certain L-PRx metrics may be considered to be applied clinically in TBI monitoring, after further 
prospective investigation. Further, these results carry implications to expand the application of 
cerebrovascular reactivity monitoring, through low-frequency L-PRx metrics, to centers without 
biomedical signal processing expertise or ability to capture high-frequency full waveform physiology. 
First, minute based mean ICP and MAP data displays similar time-series relationships, Granger causality 
and IRF plots, compared to the conventional 10-second averaged vasogenic slow-wave ICP and MAP 
data. This is important because despite the smoothing effect seen with minute based ICP and MAP data, 
and concerns about only capturing the ultra-low end of the vasogenic slow-wave frequency spectrum 
(ie. 0.005 Hz or less), minute based data appears to still carry some information regarding the ICP and 
MAP relationship seen in the higher frequency 10-second data set. This implies that minute based ICP 
and MAP data may carry information regarding cerebrovascular reactivity, supporting their use in the 
derivation of L-PRx measures.  Though we must acknowledge, the results found in this manuscript are 
preliminary and require much further validation.  
Second, despite both the Granger testing and VARIMA IRF plots indicating that the minute based data 
likely carries some information regarding cerebrovascular reactivity from the ultra-low end of the 
vasogenic slow-wave frequency range, there are some subtle findings that also suggest this data carries 
other potential information.  The magnitude of the Granger F-test statistic decreased for the MAP on ICP 
causal relationship, when evaluating the minute based data, with two patients falling out of significance 
for this relationship.  Thus, despite the causal direction between ICP and MAP remaining in favor of MAP 





less strong.  This likely stems from the fact that minute-based data captures information on the MAP 
and ICP relationship outside of the ultra-low end of the vasogenic slow-wave frequency range associated 
with cerebral autoregulation.[16,17] Similarly, the IRF plots for MAP on ICP also hint that there is 
information regarding the relationship of MAP on ICP that extends beyond the vasogenic range. This is 
highlighted by the ICP response to MAP in the IRF plots taking on the order of minutes to return to 
baseline in minute based data, where the 10-second data returns to baseline after a minute or two.  
However, even though these results suggest that minute-based data carries additional low-frequency 
information regarding the MAP and ICP relationship, beyond the ultra-low end of the vasogenic slow-
wave frequency range (ie. 0.005 Hz), it is unclear at this time what this represents.  Much further work is 
required in this area. 
Third, L-PRx variants display heterogeneous relationships with standard PRx.  This is in parallel to 
previous retrospective analysis on low frequency cerebrovascular reactivity metrics derived from 
minute-by-minute data.[19]  Based on Pearson correlation, the correlation between standard PRx and L-
PRx_5 was moderate to strong, with coefficients around 0.7 to 0.8 for most patients in this cohort.  The 
lack of stronger correlation may be related to deriving the Pearson value on 5 paired measures of ICP 
and MAP for L-PRx_5. However, of importance is the stronger relationship between L-PRx metrics based 
on short window durations with standard PRx. This was seen in the ARIMA time-series analysis and both 
LOESS and correlation testing.  This implies that if one were to use L-PRx as a measure of 
cerebrovascular reactivity, that shorter window lengths for calculation should be used, as opposed to 
the longer windows which appear to have little association with PRx derived from 10-second mean slow-
wave data.  This should not be a complete surprise, as longer window lengths for L-PRx calculation 
utilize longer periods of data recording than standard PRx or shorter window L-PRx variants. As such, 
longer L-PRx metrics are based on increasingly different data, as the window length increases. The 





standard PRx, as these have been evaluated as low-frequency cerebrovascular reactivity metrics in the 
past.[19,20] Again, our population was small, and further investigation in larger cohorts is required to 
validate the findings here. 
Fourth, it must be re-emphasized that our results do not absolutely confirm or refute L-PRx metrics as 
measures of cerebrovascular reactivity.  We only demonstrate preliminarily that aspects of L-PRx 
derivation and specific L-PRx metrics may carry similar information as standard PRx.  This is important, 
since widespread adoption of continuous cerebrovascular reactivity monitoring is hindered by the 
equipment and expertise required for high-frequency data capture and derivation of standard PRx based 
on vasogenic slow-wave frequency data.  Our results suggest a potential role for L-PRx measures as a 
surrogate for cerebrovascular reactivity monitoring, in the absence of the ability to derive PRx.  Our 
results require much further validation and exploration in larger adult TBI data sets, as well as in 
experimental animal models. Given the results of this multi-center pilot analysis, we plan on future large 
prospective data collection to explore these findings in more detail, integrating patient, injury and 
treatment characteristics. 
Finally, briefly evaluating the association between PRx and L-PRx and 6 month dichotomized GOSE 
demonstrated corollary findings that L-PRx displays similar outcome association to PRx. This is in keeping 
with previously published retrospective studies.[18–20]  Our results must be interpreted with caution 
however, given the small cohort size.  This is reflected in wide 95% CI’s.  As such, at this time we cannot 
say one metric is superior to the other, or if the lack of association between PRx and L-PRx with 
favourable/unfavourable outcome is true.  This will require much larger prospective studies, which we 
have planned.  
In summary, these results provide some support for low-frequency physiology in the derivation and 





metrics, L-PRx provides the ability for a larger number of centers globally to be able to monitor 
cerebrovascular reactivity in their critically ill cohorts, without the need for specialized biomedical signal 
processing capabilities, or high-frequency digital data, which is often not available in many centers. The 
results here imply that low-frequency physiology below the low end of the vasogenic slow wave 
spectrum (ie. 0.005Hz and below), provides at least some information regarding cerebrovascular 
reactivity. This does not mean it provides all, or even the most optimal, amount of information regarding 
cerebrovascular reactivity in TBI. The current literature body supports that the optimal slow-wave 
frequency range for vascular reactivity monitoring existing between 0.05 to 0.005Hz, as demonstrated in 
animal models interrogating the lower-limit of autoregulation during arterial hypotension.[16,17] This 
frequency range is what PRx, and similar metrics, are designed to capture. As such, when the 
opportunity to monitor cerebrovascular reactivity based on high-frequency physiologic data exists, this 
should be the goal as it provides the ability to use a vascular reactivity metric, such as PRx, which is 
derived in a manner to capture this frequency range.   L-PRx should only be considered in the setting 
where there is a lack of specialized expertise to derive PRx, or there is simply no ability to obtain higher 
frequency ICP and ABP physiology.  The latter is often the case in many centers, given limitations in data 
export options for commercially available ICU monitors. These are the situations where L-PRx carries a 
potential to improve access to cerebrovascular reactivity monitoring. 
Limitations 
Despite the promising results found, there are some limitations which deserve highlighting.  First, this is 
retrospective analysis of prospectively collected data, in a small data set.  As such, our findings can only 
be considered exploratory and preliminary in nature. The 31 patients were selected based on these 
being the only TBI patients from the 3 centers with available ICM+ data for analysis.  As such, the results 
here may not be generalizable to other TBI populations, necessitating much needed validation. Second, 





is something that can only be accounted for in larger prospective multi-center data sets. This can be 
highlighted by the fact that 3 of the 31 patients had EVD’s. Though in this particular cohort there was no 
difference found in the relationship between PRx and L-PRx, compared to the non-EVD cohort, when 
looking at the individual patient level, there exists the potential that such differences in monitoring 
devices, and therapies given, may impact the statistical signal properties.  As such, the results here 
should be interpreted as preliminary, requiring much further validation prior to widespread adoption of 
L-PRx for clinical monitoring in adult TBI. Finally, the statistical methodology employed was 
computationally tasking.  Larger prospective studies will benefit from more robust central computing 
services in order to accomplish analysis in a timely fashion. 
 
Conclusions: 
ICP and MAP derived via 10-sec or minute based averaging display similar time-series statistical 
structure and co-variance patterns.  PRx and L-PRx also behave similarly over time, with those L-PRx 
indices derived from longer time-windows displaying less association with standard PRx derived from 
higher frequency data. These results imply certain short window L-PRx variants may carry similar 
information to PRx in TBI.   
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Figure 1: PRx and L-PRx Variant Behaviour over Time – Patient Example 
ICP = intra-cranial pressure, MAP = mean arterial pressure, PRx = pressure reactivity index (correlation between ICP and MAP), L-
PRx_5 = correlation between minute based ICP and MAP (5-min window length), L-PRx_20 = correlation between minute based 
ICP and MAP (20-min window length), L-PRx_60 = correlation between minute based ICP and MAP (60-min window length). 
NOTE: Longer window lengths leads to further data smoothing for L-PRx and loss of signal variance in time. 
 
 
Figure 2: VARIMA Impulse Response Function Plots of MAP Acting on ICP – Two Patient Examples 
ICP = intra-cranial pressure, lag = previous measure in time (x 10-sec = means 1 lag is 10-seconds in time; x min = means 1 lag is 
1 minute in time), MAP = mean arterial pressure, VARIMA = vector autoregressive integrative moving average models (for all 
patients autoregressive order was 4, integrative order 1, and moving average order 4). Panel A and B = Patient 1, and Panel C 
and D = Patient 2. Plots demonstrate transformed and differenced (ie. de-trended) minute mean ICP and MAP data (Panel B and 
D), and 10-second mean data (Panel A and C). Plots display the impact of one standard deviation impulse in MAP on the 
standard error in ICP from the VARIMA models. Both examples highlight some smoothing in response seen with minute mean 
data, however the general response in ICP to MAP impulse is similar between minute and 10-second mean data. 
 
Figure 3: LOESS and Bland-Altman Plots for PRx vs. L-PRx_5 and PRx vs L-PRx_30 – Patient Example 
a.u. = arbitrary units, ICP = intra-cranial pressure, LOESS = locally weighted scatterplot smoothing function, MAP = mean arterial 
pressure, PRx = pressure reactivity index (correlation between ICP and MAP), L-PRx_5 = correlation between minute based ICP 
and MAP (5-min window),  L-PRx_30 = correlation between minute based ICP and MAP (30-min window) 
 
